Use of an Acellular Assay to Study Interactions between Actinides and Biological or Synthetic Ligands.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
24 10 2022
Historique:
received: 26 09 2022
revised: 18 10 2022
accepted: 20 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Speciation of actinides, and more particularly bioligand-binding ability, influences in vivo behavior. Understanding these interactions is essential for estimation of radiological dose and improvement of decorporation strategies for accidentally contaminated victims. Because the handling of actinides imposes overwhelming difficulties, in vitro assays carried out in physiological conditions are lacking and data regarding such interactions are scarce. In this study, we used a bi-compartmental and dynamic assay, providing physiological conditions (presence of inorganic ions, pH, temperature) to explore interactions between the actinides plutonium (Pu) and americium (Am) and endogenous (proteins transferrin and ferritin) or exogenous ligands (the chelating agent diethylenetriaminpentaacetic acid, DTPA). In this assay, an agarose gel represents the retention compartment of actinides and a dynamic fluid phase, the transfer compartment. The proportion of actinides transferred from static to dynamic phase reflects interactions between Pu/Am and various ligands. The results show differences in the formation of actinide-protein or actinide-DTPA complexes in physiologically relevant media depending on which ligand is present and where. We observed differential behavior for Pu and Am similar to in vivo studies. Thus, our assay may be used to determine the ability of various actinides to interact with specific proteins or with drug candidates for decorporation in complex physiologically relevant environments.

Identifiants

pubmed: 36358903
pii: biom12111553
doi: 10.3390/biom12111553
pmc: PMC9687942
pii:
doi:

Substances chimiques

Ligands 0
Actinoid Series Elements 0
Americium VW92PHU2UY
Plutonium 53023GN24M
Pentetic Acid 7A314HQM0I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Radiat Res. 2010 Nov;174(5):637-44
pubmed: 20726717
Health Phys. 1972 Jun;22(6):575-81
pubmed: 5083989
J Clin Pathol. 1973 Oct;26(10):770-2
pubmed: 4750458
Phys Med Biol. 1968 Oct;13(4):535-46
pubmed: 5683324
J Synchrotron Radiat. 2022 Jan 1;29(Pt 1):45-52
pubmed: 34985422
Radiat Res. 1970 Jul;43(1):173-86
pubmed: 5450341
Radiat Prot Dosimetry. 2003;105(1-4):521-5
pubmed: 14535232
Health Phys. 2021 Mar 1;120(3):258-270
pubmed: 32881734
Radiat Res. 1969 Feb;37(2):349-60
pubmed: 5765545
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10342-7
pubmed: 26240330
Biochimie. 2006 Nov;88(11):1605-18
pubmed: 16996675
Hum Exp Toxicol. 1995 Jan;14(1):38-48
pubmed: 7748615
Toxicol In Vitro. 2022 Mar;79:105279
pubmed: 34843884
Nat Chem Biol. 2011 Jun 26;7(8):560-5
pubmed: 21706034
J Am Chem Soc. 2021 Sep 29;143(38):15769-15783
pubmed: 34542285
Clin Sci (Lond). 1986 Dec;71(6):729-35
pubmed: 3024899
Ann ICRP. 2015 Sep;44(2):5-188
pubmed: 26494836
Toxicol In Vitro. 2019 Aug;58:142-149
pubmed: 30905861
Health Phys. 1962 Dec;8:717-24
pubmed: 13954076
Ann ICRP. 2019 Dec;48(2-3):9-501
pubmed: 31850780
Sci Total Environ. 1989 Jul 15;83(3):217-25
pubmed: 2781271
Front Pharmacol. 2021 Mar 26;12:635792
pubmed: 33841153
J Radiat Res. 1980 Mar;21(1):111-7
pubmed: 7381808
Radiat Prot Dosimetry. 2007;125(1-4):506-12
pubmed: 17298952
J Biol Chem. 1978 Jun 25;253(12):4451-8
pubmed: 659425
Drug Discov Today. 2005 Feb 15;10(4):267-73
pubmed: 15708745
J Struct Biol. 2009 Apr;166(1):22-31
pubmed: 19116170
Chemistry. 2010 Jan 25;16(4):1378-87
pubmed: 19950335
Health Phys. 1971 Aug;21(2):197-204
pubmed: 5094190
Health Phys. 1969 Mar;16(3):339-40
pubmed: 5787748
Biochemistry. 1998 Jun 2;37(22):7919-28
pubmed: 9609685
Chemistry. 2021 Feb 1;27(7):2393-2401
pubmed: 32955137
Radiat Res. 2016 Jun;185(6):568-79
pubmed: 27195610
Health Phys. 2019 Aug;117(2):133-142
pubmed: 29595754
Antioxidants (Basel). 2021 Sep 09;10(9):
pubmed: 34573070
Nature. 1965 Oct 16;208(5007):282-3
pubmed: 5882454
Klin Wochenschr. 1985 Sep 2;63(17):781-7
pubmed: 4057910
Dalton Trans. 2017 Jan 31;46(5):1389-1396
pubmed: 28112296
Health Phys. 1972 Jun;22(6):657-65
pubmed: 5083996
Hum Exp Toxicol. 1990 Jan;9(1):17-24
pubmed: 2328142
J Anat. 1996 Dec;189 ( Pt 3):521-30
pubmed: 8982826
Health Phys. 1991 Mar;60(3):307-33
pubmed: 1847360
Sci Rep. 2019 Nov 26;9(1):17584
pubmed: 31772265
Health Phys. 2016 Aug;111(2):93-9
pubmed: 27356051
Nanoscale. 2021 Oct 28;13(41):17318-17324
pubmed: 34642724

Auteurs

Anne Van der Meeren (A)

Laboratory of Radio Toxicology, Commissariat à l'énergie atomique et aux energies alternatives (CEA), Paris-Saclay University, 91297 Arpajon, France.

Catherine Berthomieu (C)

Protein-Metal Interactions Laboratory, Commissariat à l'énergie Atomique et aux Energies Alternatives (CEA), Aix Marseille University, Centre National de Recherche Scientifique (CNRS), 13108 Saint Paul-Lez-Durance, France.

Agnès Moureau (A)

Laboratory of Radio Toxicology, Commissariat à l'énergie atomique et aux energies alternatives (CEA), Paris-Saclay University, 91297 Arpajon, France.

Martine Defrance (M)

Laboratory of Radio Toxicology, Commissariat à l'énergie atomique et aux energies alternatives (CEA), Paris-Saclay University, 91297 Arpajon, France.

Nina M Griffiths (NM)

Laboratory of Radio Toxicology, Commissariat à l'énergie atomique et aux energies alternatives (CEA), Paris-Saclay University, 91297 Arpajon, France.

Articles similaires

Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Proteins Protein Binding Ligands Internet Databases, Protein

Orientation-dependent CD45 inhibition with viral and engineered ligands.

Marta T Borowska, Liu D Liu, Nathanael A Caveney et al.
1.00
Leukocyte Common Antigens Humans Ligands T-Lymphocytes Viral Proteins
Molecular Docking Simulation Protein Kinase Inhibitors Protein Binding Ligands Drug Discovery

Classifications MeSH